logo

Trovagene Inc. (TROV)



Trade TROV now with
  Date
  Headline
5/6/2020 8:19:53 AM Trovagene Announces Changing Of Company Name To Cardiff Oncology And Appointment Of Mark Erlander As CEO
4/1/2020 8:17:27 AM Trovagene Says Phase 1b/2 KRAS-mCRC Trial Abstract To Be Presented At The 2020 ASCO Annual Meeting
3/5/2020 8:16:52 AM Trovagene Announces Three New Nominees To Board
2/13/2020 8:10:59 AM Trovagene Announces Positive Data From Phase 2 Trial Of Onvansertib In Combination With Zytiga/prednisone
11/14/2019 8:08:40 AM Trovagene Presents Positive Data In Metastatic Prostate Cancer Phase 2 Trial S
11/6/2019 9:13:42 AM Trovagene Announces Data From Acute Myeloid Leukemia Phase 1b/2 Trial Of Onvansertib Chosen For Oral Presentation
10/22/2019 8:17:11 AM Trovagene Announces Positive Response To Treatment In Phase 1b/2 Trial Of Onvansertib
9/30/2019 8:26:20 AM Trovagene Presents Results From Phase 1b/2 Study Of Onvansertib In Patients With Relapsed/refractory AML
9/19/2019 8:16:36 AM Trovagene Reports Completion Of Phase 1b Trial Of Onvansertib In Acute Myeloid Leukemia
8/26/2019 8:08:31 AM Trovagene Presents Positive Clinical Data From Ongoing Phase 2 Study Of Onvansertib In MCRPC